Skip to main content
Top

Breast Cancer

Issue 6/2018

Content (19 Articles)

Original Article

Survival analysis according to period and analysis of the factors influencing changes in survival in patients with recurrent breast cancer: a large-scale, single-center study

Sae Byul Lee, Guiyun Sohn, Jisun Kim, Il Yong Chung, Jong Won Lee, Hee Jeong Kim, Beom Seok Ko, Byung Ho Son, Sei-Hyun Ahn

Original Article

Real-time navigation system for sentinel lymph node biopsy in breast cancer patients using projection mapping with indocyanine green fluorescence

Masahiro Takada, Megumi Takeuchi, Eiji Suzuki, Fumiaki Sato, Yoshiaki Matsumoto, Masae Torii, Nobuko Kawaguchi-Sakita, Hiroto Nishino, Satoru Seo, Etsuro Hatano, Masakazu Toi

Original Article

Impact of visual feedback on dose-volume histograms for organs at risk in postoperative radiotherapy with deep inspiration breath-holding for patients treated with breast-conserving therapy: a planning study

Keiko Nemoto Murofushi, Masaru Nakajima, Tetsuya Tomita, Minako Sumi, Yasuo Yoshioka, Masahiko Oguchi, Hideyuki Sakurai

Original Article

Upstaging to invasive ductal carcinoma after mastectomy for ductal carcinoma in situ: predictive factors and role of sentinel lymph node biopsy

Yusuke Watanabe, Keisei Anan, Michiyo Saimura, Kenichiro Koga, Minoru Fujino, Mari Mine, Sadafumi Tamiya, Kazuyoshi Nishihara, Toru Nakano, Shoshu Mitsuyama

Original Article

Artesunate promotes G2/M cell cycle arrest in MCF7 breast cancer cells through ATM activation

Lijuan Wen, Lei Liu, Lina Wen, Tao Yu, Fengxiang Wei

Original Article

Functional heterogeneity of circulating T regulatory cell subsets in breast cancer patients

Yekaterina O. Ostapchuk, Yuliya V. Perfilyeva, Elena A. Kustova, Natalya T. Urazalieva, Nazgul A. Omarbaeva, Shynar G. Talaeva, Nikolai N. Belyaev

Original Article

Clinicopathological significance of cancer stem cell markers CD44 and ALDH1 expression in breast cancer

Tahani Louhichi, Sonia Ziadi, Hanene Saad, Myriam Ben Dhiab, Sarra Mestiri, Mounir Trimeche

Original Article

Breast cancer stem cells characterized by CD70 expression preferentially metastasize to the lungs

Li Liu, Bo Yin, Zhu Yi, XiuJuan Liu, ZhiQian Hu, WenChao Gao, HaiWen Yu, QingQuan Li

Original Article

The efficacy and feasibility of dose-dense sequential chemotherapy for Japanese patients with breast cancer

Daisuke Takabatake, Yukiko Kajiwara, Shoichiro Ohtani, Yoko Itano, Mari Yamamoto, Shinichiro Kubo, Masahiko Ikeda, Mina Takahashi, Fumikata Hara, Kenjiro Aogi, Shozo Ohsumi, Yutaka Ogasawara, Yoshitaka Nishiyama, Hajime Hikino, Kinya Matsuoka, Yuko Takahashi, Tadahiko Shien, Naruto Taira, Hiroyoshi Doihara

Original Article

A randomized phase II study evaluating pyridoxine for the prevention of hand–foot syndrome associated with capecitabine therapy for advanced or metastatic breast cancer

Tatsuya Toyama, Akiyo Yoshimura, Takako Hayashi, Naomi Kobayashi, Kanako Saito, Michiko Tsuneizumi, Masataka Sawaki, Masaya Hattori, Takumi Nakada, Isao Yokota, Hiroji Iwata

Original Article

Repeat recurrence and malignant transition of phyllodes tumors of the breast

Asaka Wada, Naoki Hayashi, Fumi Endo, Hiroko Tsunoda, Atsushi Yoshida, Koyu Suzuki, Seigo Nakamura, Hideko Yamauchi

Open Access Original Article

Use of fiberoductoscopy for the management of patients with pathological nipple discharge: experience of a single center in Poland

Jacek Zielinski, Radoslaw Jaworski, Ninela Irga-Jaworska, Michal Pikula, Michael Hunerbein, Janusz Jaskiewicz

Original Article

Comprehensive immunohistochemical analyses on expression levels of hedgehog signaling molecules in breast cancers

Junichi Kurebayashi, Naoki Kanomata, Yoshikazu Koike, Yusuke Ohta, Wataru Saitoh, Emi Kishino

Original Article

Comparison of Ki-67 labeling index measurements using digital image analysis and scoring by pathologists

Toru Morioka, Naoki Niikura, Nobue Kumaki, Shinobu Masuda, Takayuki Iwamoto, Kozue Yokoyama, Rin Ogiya, Risa Oshitanai, Mayako Terao, Banri Tsuda, Takuho Okamura, Yuki Saito, Yasuhiro Suzuki, Yutaka Tokuda

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine